title: Usefulness of technetium-99m sestamibi infarct size in predicting posthospital mortality following acute myocardial infarction.
abstract: In this multicenter study, 249 patients who underwent tomographic technetium-99m sestamibi infarct size measurement at hospital discharge were followed up for a median duration of 7 months. Infarct size was significantly associated with mortality (chi-square = 5.8, p = 0.02) and could stratify patients into lower and higher risk subsets: 1-year mortality 2% for infarct size < 14% versus 8% for infarct size > or = 14% of the left ventricle.
authors.affiliation: Mayo Clinic, Rochester, Minnesota 55905, USA.
authors.forename: T D
authors.initials: TD
authors.lastname: Miller
authors.forename: D O
authors.initials: DO
authors.lastname: Hodge
authors.forename: J M
authors.initials: JM
authors.lastname: Sutton
authors.forename: C L
authors.initials: CL
authors.lastname: Grines
authors.forename: J H
authors.initials: JH
authors.lastname: O'Keefe
authors.forename: M A
authors.initials: MA
authors.lastname: DeWood
authors.forename: R D
authors.initials: RD
authors.lastname: Okada
authors.forename: W O
authors.initials: WO
authors.lastname: Fletcher
authors.forename: R J
authors.initials: RJ
authors.lastname: Gibbons
mesh_terms: D000368:Aged; D016009:Chi-Square Distribution; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000000981:diagnostic imaging* / Q000401:mortality*; D010351:Patient Discharge; D011237:Predictive Value of Tests; D011877:Radionuclide Imaging; D019275:Radiopharmaceuticals; D016019:Survival Analysis; D017256:Technetium Tc 99m Sestamibi
chemical_list: D019275:Radiopharmaceuticals; D017256:Technetium Tc 99m Sestamibi